李艳春

    [关键词] 糖尿病;糖尿病性视网膜病变;糖尿病性黄斑水肿;药物治疗

    [中图分类号] R587.2? ? ? ? ? [文献标识码] A? ? ? ? ? [文章编号] 1673-9701(2021)18-0184-04

    Status quo of medication for diabetic macular edema

    LI Yanchun

    Department of Ophthalmology， the Second Peoples Hospital of Qinzhou City in Guangxi Zhuang Autonomous Region， Qinzhou? ?535099， China

    [Abstract] Diabetic macular edema and proliferative diabetic retinopathy are the two main causes of visual impairment in patients with diabetic retinopathy， and diabetic macular edema is the main cause of visual impairment in non-proliferative diabetic retinopathy. At present， the treatment methods of diabetic macular edema include fundus laser， medication and vitreous surgery. Vascular endothelial growth factor and inflammatory factors play a very important role in the occurrence and development of diabetic macular edema， and inflammatory factors and vascular endothelial growth factor stimulate each other to secrete and promote the formation of diabetic macular edema. Therefore， the targeted medications mainly include anti-vascular endothelial growth factor drugs and corticosteroid drugs. Based on the deepening research of anti-vascular endothelial growth factor drugs and corticosteroid drugs in recent years ......